NATCO Pharma Limited announces the launch of additional strengths for the generic version of Revlimid (lenalidomide capsules), in 2.5 mg, and 20 mg strengths, in the United States, via an exchange filing.
The launch is through its marketing partner Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd.
With this launch the companies made available all the strengths of lenalidomide in the US market.
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
FPJ Interview: Kashmir After Pahalgam Attack – Responsibility, Reality And Road Ahead; VIDEO
Rahul Gandhi To Begin 2-Day Visit To Rae Bareli & Amethi On April 29
Muslim Community Alleges Harassment Post-Pahalgam Attack; SP MLA Azmi Demands Action Against Nitesh Rane
Mumbai's Government School Students Showcase Play Inspired By Warli Community’s Storytelling Traditions At Yashwant Natya Mandir
